| Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data DR Tyson, SP Garbett, PL Frick, V Quaranta Nature Methods 9 (9), 923-928, 2012 | 123 | 2012 |
| An unbiased metric of antiproliferative drug effect in vitro LA Harris, PL Frick, SP Garbett, KN Hardeman, BB Paudel, CF Lopez, ... Nature Methods, 2016 | 109 | 2016 |
| Quantifying heterogeneity and dynamics of clonal fitness in response to perturbation PL Frick, BB Paudel, DR Tyson, V Quaranta Journal of cellular physiology 230 (7), 1403-1412, 2015 | 32 | 2015 |
| Quantifying cancer heterogeneity to predict and improve targeted therapy outcomes PL Frick Vanderbilt University, 2014 | 2 | 2014 |
| Cell Cycle, Cancer Cell Cycle and Oncogene Addiction V Quaranta, D Tyson, P Frick Encyclopedia of Systems Biology, 341-343, 2013 | 2 | 2013 |
| Identification of NSCLC biomarkers underlying quantifiable drug-induced clonal fitness KL Jameson, PL Frick, DR Tyson, TE Yankeelov, V Quaranta Cancer Research 75 (15 Supplement), 3747-3747, 2015 | | 2015 |
| Sensitivity of PC9 cells to erlotinib is affected by extracellular matrix HM Onishko, J Zhao, KL Jameson, PL Frick, DR Tyson, V Quaranta, ... Cancer Research 74 (19 Supplement), 1845-1845, 2014 | | 2014 |
| Quantifying erlotinib response variability in EGFR-addicted cells. PL Frick, DR Tyson, SP Garbett, CF Lopez, ZW Jones, V Quaranta Cancer Research 73 (8 Supplement), 4626-4626, 2013 | | 2013 |
| 1403 Quantifying Heterogeneity and Dynamics of Clonal Fitness in Response to Perturbation PL FRICK, BB PAUDEL, DR TYSON, V QUARANTA | | |
